Features

Features

• Considerations in Pediatric Clinical Trials, Ensuring Patient Safety

  Pediatric clinical trials have the potential to address many unmet needs and gaps in healthcare; however, contemplating the many considerations in pediatric clinical trials is essential for mitigating concerns and ensuring patient safety.  Continue Reading

• Understanding Pharmaceutical Recalls, Key Players, and Their Roles

  For key players such as the FDA, manufacturers, and other healthcare professionals, understanding pharmaceutical recalls, procedures, and obligations are necessary for ensuring patient safety.  Continue Reading

• Navigating Male Reproductive Care in a Post-Roe World, Vasectomies

  As patients, providers, and public health experts work to navigate male reproductive healthcare in a post-Roe world, addressing common misconceptions around vasectomies can help clinicians provide more comprehensive patient consultations.  Continue Reading

• Deciding Which Depression Screening Tools to Use

  Incorporating depression screenings can help improve patient care, facilitate early diagnosis and treatment, and decrease healthcare spending; however, providers are tasked with deciding which depression screening tools to use based on their ...  Continue Reading

• Preventing Prescription Drug Fraud

  Preventing prescription drug fraud is a complex process necessary for minimizing the rate of prescription drug abuse, combatting addiction, and saving money for the healthcare industry.  Continue Reading

• Closing Obesity Care Gaps: Understanding Trends and Treatments

  Understanding the trends, prevention strategies, and treatments for obesity can help members of the healthcare industry work toward closing care gaps in obesity, impacting nearly half of all adults in the United States.  Continue Reading

• Respiratory Medications, Understanding Options, and Indications

  With the rising rates of respiratory illness that have accompanied the COVID-19 pandemic, understanding the options and indications for respiratory medications is critical for healthcare professionals.  Continue Reading

• Challenges of Improving Access to Digital Therapeutics in Healthcare

  As medicine and software converge, digital therapeutics are rapidly transforming healthcare, but manufacturers face several challenges that prevent patient access and widespread reimbursement.  Continue Reading

• Preparing Patients for Stem Cell Transplants, Challenges

  With a global average of 84,000 stem cell transplants occurring each year, providers are responsible for preparing patients for stem cell transplants and addressing the associated challenges.  Continue Reading

• How to Improve Regulatory Measures for Dietary Supplements

  Considering that 80% of adults in the United States use or have used dietary supplements, improvements to the current regulatory measures for dietary supplements are vital.  Continue Reading

• Initiating Dementia Treatment, Pharmacological Interventions

  Initiating the pharmacological treatment and symptom management of dementia is complex as each of the 55 million people with dementia worldwide has different reactions to currently available medications.  Continue Reading

• Achieving Adequate Pain Management, Pharmacological Indications

  Achieving adequate pain management for the 20.4% of adults in the US struggling with chronic pain involves understanding pharmacological indications and contraindications.  Continue Reading

• Preventing Surgical Site Infections, Complexities of Operative Care

  With up to 3% of operative patients experiencing surgical site infections (SSI), understanding how to prevent and treat SSIs in complex pre-, peri-, and post-operative care settings can improve patient outcomes.  Continue Reading

• Understanding FDA Advisory Committees, Aims, and Members

  The FDA advisory committees, composed of multiple members of different disciplines, aim to provide evidence-based recommendations for the FDA’s regulatory decisions.  Continue Reading

• Applying Augmented and Virtual Reality in Healthcare

  The rise of augmented and virtual reality has led to many healthcare applications, presenting new treatment options and widening accessibility.  Continue Reading

• Pharmaceutical Automation Alleviates Burnout

  With over 60% of pharmacists experiencing burnout, pharmaceutical automation has been proposed to alleviate some of the workload and pressure contributing to automation.  Continue Reading

• Applications of 3D Printing, Enhancing Precision Medicine

  Applications of 3D printing in medicine have expanded since its start in the 1980s, enhancing precision medicine, addressing supply chain issues, and expanding educational opportunities.  Continue Reading

• Disease-Modifying Antirheumatic Drugs Effectively Treat Arthritis

  With 43.5% of arthritis patients experiencing some limitations, providers have begun to opt for disease-modifying antirheumatic drugs to treat rheumatoid arthritis effectively.  Continue Reading

• Pharmacists Are Excluded in Burnout Conversations

  Despite playing a significant role in the healthcare industry and experiencing rates of burnout equal to or higher than other healthcare professions, pharmacists are excluded from conversations about burnout.  Continue Reading

• Adderall Withdrawal Exacerbated by Pharmaceutical Supply Chain Issues

  The recent Adderall shortages in the United States have exacerbated withdrawal symptoms and contributed to medication rationing.  Continue Reading

• Exploring Non-Pharmacological Interventions for Epilepsy

  With 50 million people worldwide struggling with epilepsy, understanding treatment options, including non-pharmacological interventions, is essential for delivering effective symptom relief.  Continue Reading

• Pancreatic Cancer Deaths Are Expected to Surpass Colorectal Cancer Deaths

  Based on increased global incidence and mortality rates, experts expect pancreatic cancer deaths to surpass colorectal cancer deaths by 2030.  Continue Reading

• Understanding the Need for New UTI Treatments

  UTIs are an unfortunately common experience for many women worldwide; however, complexities with recurrence, relapse, and antibiotic resistance have created a need for new treatment methods.  Continue Reading

• Unpacking the 340B Drug Pricing Program, Its Impact on the Pharmaceutical Industry

  The 340B Drug Pricing Program is a key resource for outpatient prescription drug access, but recent conflicts have altered the pharmaceutical industry’s role in the federal program.  Continue Reading

• Understanding the FDA’s Expedited Approval Pathways

  Understanding the FDA’s expedited approval pathways, Fast Track, Breakthrough Therapy, Priority Review, and Accelerated Approval, is essential for patients, payers, and providers, as a majority of approved drugs in 2021 underwent one of these ...  Continue Reading

• Exploring the Benefits of a Collaborative Global Pharmaceutical Industry

  As healthcare professionals call for collaboration, exploring the historical and projected benefits of a collaborative global pharmaceutical industry is necessary to incentivize industry leaders to contribute.  Continue Reading

• Clinical Pharmacists Are a Major Contributor to Quality Patient Care

  As the popularity of clinical pharmacists continues to rise, understanding their role, history, and benefits shows that they significantly contribute to quality patient care.  Continue Reading

• Understanding the Rise of Digital Pharmacies

  The rise of digital pharmacies, while beneficial in some respects, comes with its own set of drawbacks for patients, payers, and providers.  Continue Reading

• How Antibiotics and Antibiotic Resistance Transformed Medicine

  The development, discovery, and distribution of antibiotics and the subsequent rise of antibiotic resistance have transformed medicine.  Continue Reading

• How AI Can Help Diagnose and Streamline Care for Diabetic Retinopathy

  AI technology may be able to facilitate early diagnosis and streamlined care for diabetic retinopathy in specialized, primary care, and mobile settings.  Continue Reading

• Understanding Differences between Generic, Brand Name, Biosimilars

  Knowledge of and understanding the differences between generics, brand names, and biosimilars is essential for patients, payers, and providers to make informed decisions about care.  Continue Reading

• Patients, Providers, and the Public Hesitate to Adopt Digital Pills

  Among patients, providers, and the general public, there is a hesitancy to adopt digital pills due to ethical, fiscal, and safety concerns.  Continue Reading

• How Antirejection Drugs Can Promote Successful Transplants

  Antirejection drugs are complex and significantly promote a successful transplant before and after the procedure.  Continue Reading

• How A Prescription Drug Becomes Available Over the Counter

  Considering the recent efforts to make oral contraceptives available over the counter, understanding the FDA guidelines on how a drug becomes available over the counter is essential for the industry.  Continue Reading

• NIH’s Bridge to Artificial Intelligence Facilitates Scientific Collaboration

  Bridge to Artificial Intelligence, an NIH Common Fund Program, optimizes data and tools to facilitate scientific collaboration and biomedical advancements.  Continue Reading

• How Continuous Glucose Monitors Have Impacted Chronic Disease Management

  Continuous glucose monitors have impacted chronic disease management for patients with diabetes and clinicians by providing additional insight into blood sugar changes.  Continue Reading

• How Biden’s Equitable Access to Research Will Impact Healthcare

  In an interview with PharmaNewsIntelligence, Ariel Katz, CEO of H1, a global healthcare data provider, discussed how the Biden administration’s order for equitable access to research will impact healthcare.  Continue Reading

• Explaining the Comprehensive Approach to PTSD Diagnosis

  PTSD, like many other neurological and psychiatric conditions, is a complex condition that can be mistaken for other disorders, which is why PTSD diagnosis is comprehensive and multifaceted.  Continue Reading

• IVF Provides Additional Resources in Reproductive Health

  In vitro fertilization (IVF) provides an additional resource for those unable to conceive naturally, expanding the tools used in reproductive health.  Continue Reading

• How Chemotherapy Drugs Impact Cells, Patients, and the Healthcare System

  Chemotherapy drugs have multiple impacts, including slowing cell proliferation, improving patient outcomes, and stressing the healthcare system.  Continue Reading

• Chronic Disease Rates and Management Strain the US Healthcare System

  The rate of chronic disease and the resources required for its management strain the healthcare system due to the resources and costs associated with care.  Continue Reading

• Understanding the Burdens of Dialysis

  For patients with chronic kidney disease that progresses into end-stage renal failure, dialysis is an additional burden that impacts lifestyle and financial security.  Continue Reading

• Smallpox, Chickenpox, Mpox: Understanding the Differences

  The recent emergence of mpox has brought about confusion about the differences between the three viral infections.  Continue Reading

• A History of Insulin Development and Insulin Delivery Systems

  In recent years, insulin has caught media attention due to its increasing costs; understanding the basics of insulin and delivery systems can help us better understand how to address the prices.  Continue Reading

• The Pipeline of Male Contraceptives: Shifting the Burden of Pregnancy Prevention

  The discovery of innovative male contraceptives could shift the burden of pregnancy prevention, leading to equal contraceptive options across genders.  Continue Reading

• The Global Spread of Mpox: Origins, Symptoms, and Treatment

  The recent global spread of mpox has led professionals to investigate and analyze the virus's origins, symptoms, and treatments.  Continue Reading

• How Pharmaceutical Patents Contribute to Increased Drug Costs

  Patents in the pharmaceutical industry contribute to increased drug costs and create barriers to healthcare accessibility.  Continue Reading

• A Condensed Overview of Aging: Life Expectancy, Risk, and Research

  Increased life expectancy has led researchers to analyze the risks of aging and research its origins, preventions, and treatments.  Continue Reading

• A History of Antivirals: Mechanisms, Classes, and Subtypes

  Understanding the history, mechanisms, classes, and subtypes of antivirals may help inform the development and distribution of such drugs.  Continue Reading

• Understanding the Polio Outbreak: History and Prevention

  Understanding the history of polio and its outbreak can help inform public health strategies and prevention, considering the recent discovery of cases in the United States.  Continue Reading

• Limited Access to Female Contraceptives: A Public Health Crisis

  Limited access and understanding of female contraceptives have posed a threat to women, causing a public health crisis.  Continue Reading

• Understanding Schizophrenia: Stigma, Symptoms, Risk, and Treatment

  Understanding the symptoms, risk factors, and treatments for schizophrenia may minimize the stigma surrounding the disorder and reduce barriers to care.  Continue Reading

• Uncovering Inequities in the US Organ Transplant System

  While organ transplants are a major medical innovation that has played a hand in improving patient outcomes, numerous inequities in the system fail recipients and donors.  Continue Reading

• How Pharmaceutical Companies Have Exacerbated the Opioid Epidemic

  Drug use, specifically the opioid epidemic, has been an ever-present public health crisis exacerbated by pharmaceutical companies in the United States since the late 1900s.  Continue Reading

• The Complexities of Chronic Kidney Disease and Its Stages

  Chronic kidney disease is a multifaceted, irreversible disorder that progresses in multiple stages.  Continue Reading

• Understanding the Multifaceted Aspects of Dementia, Its Stages, Subtypes

  Dementia, a blanket term for a group of diseases that impair cognition and motor function, affects 55 million people worldwide and is expected to double in prevalence by 2050.  Continue Reading

• Revolutions in Neuroscience: Deep Brain Stimulation

  Deep brain stimulation is a major revolution in neuroscience that has provided additional options for treatment-resistant neurological disorders.  Continue Reading

• Understanding the Risk of Tickborne Diseases to Public Health

  Incidents of tickborne diseases have increased rapidly in the last two decades, posing a threat to public health.  Continue Reading

• Comprehending Climate Change Implications in an Ever-Changing Healthcare System

  Climate change and its environmental health implications are significantly ratcheting up healthcare costs and increasingly threaten physicians' ability to protect the health of patients.  Continue Reading

• Exploring Antidepressants: Selective Serotonin Reuptake Inhibitors (SSRIs)

  Selective serotonin reuptake inhibitors are the most commonly prescribed medications for treating major depressive disorder, anxiety disorders, and other psychological conditions.  Continue Reading

• Major Milestones in Medicine, Drug Development in Recorded History

  The past few centuries have witnessed several revolutionary milestones in modern medicine and drug development that have drastically improved human health.  Continue Reading

• Defining Precision Medicine and Evaluating Its Healthcare Impacts

  Precision medicine is a change from the one-size-fits-all treatment and prevention approach traditionally used in healthcare by examining a person’s genes, behaviors, and environment.  Continue Reading

• Understanding the Cognitive and Health Effects of Sleep Duration

  Sleep is an essential, life-sustaining function required for maintaining optimal health and well-being, but do we know why?  Continue Reading

• Understanding the Science Behind Allergies, Antihistamine Response

  Understanding the science behind allergies and the human antihistamine response is complicated, and researchers believe environmental and genetic factors are to blame.  Continue Reading

• How Regulation Stymies Medical Research of Controlled Substances

  Barriers to medical research constructed by federally controlled substance scheduling and classification stifle the development of safe and effective products aimed to improve overall human health.  Continue Reading

• CRISPR Genome-Editing Technology: The Future of Gene Editing

  CRISPR genome-editing technology has revolutionized genetic engineering by introducing the ability to alter an organism’s DNA to precision medicine.  Continue Reading

• Understanding the Value, Complexity of Clinical Trials in the US

  Clinical trials in the US study new drug developments and evaluate the effects in humans.  Continue Reading

• Understanding US Food and Drug Administration (FDA) Approval Processes

  The FDA approvals process is complex and time-consuming, taking an average of 12 and 7 years for drugs and devices, respectively.  Continue Reading

• Flu Vaccine Patterns Hint To Effective COVID-19 Vaccination Efforts

  Flu vaccine strategies give a glimpse into the challenges of COVID-19 vaccination efforts. Effective COVID-19 vaccine rollout can take several pointers from the flu’s failings and successes.  Continue Reading

• What is Medicare Part D, What Does It Mean for Pharma?

  Medicare Part D plans fill a coverage gap, giving members voluntary coverage for outpatient prescription drugs.  Continue Reading

• Warp Speed COVID-19 Clinical Trials Boost Future Vaccine Development

  Vaccine development is generally a time-consuming process, but the unprecedented speed of COVID-19 clinical trials will have implications across the pharmaceutical industry.  Continue Reading

• How COVID-19 Is Changing Pharmaceutical Research and Development

  As the drug companies hurry to develop a coronavirus vaccine, they are also reshaping the pharmaceutical research and development landscape for the future.  Continue Reading